Rankings
▼
Calendar
TEVA Q1 2016 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$36B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.8B
Gross Profit
$2.8B
58.0% margin
Operating Income
$1.2B
24.2% margin
Net Income
$570M
11.9% margin
EPS (Diluted)
$0.62
Cash Flow
Operating Cash Flow
$1.4B
Free Cash Flow
$1.2B
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$55.1B
Total Liabilities
$24.5B
Stockholders' Equity
$30.4B
Cash & Equivalents
$6.0B
← FY 2016
All Quarters
Q2 2016 →
